Primidone Tablets 250 mg
American Health Packaging recalls Primidone Tablets 250 mg due to trace Acemetacin contamination.
Consumers who have the affected Primidone Tablets should stop using them and contact their healthcare provider or pharmacist for guidance. Return the product to the place of purchase for a refund or replacement.
Why it was recalled
American Health Packaging is recalling Primidone Tablets, USP, 250 mg, 100 tablets per carton, due to cross-contamination with trace amounts of Acemetacin API. The affected product is distributed by American Health Packaging, Columbus, Ohio.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Primidone Tablets, USP
| Lot code | Strength | NDC / UPC | Recall # |
|---|---|---|---|
| 1028739, 2027, 1025622 | 50 mg | NDC 68084-202-01, NDC 68084-202-11 | D-0537-2026 |
| 1027583, 2027 | 250 mg | NDC 68084-203-01, NDC 68084-203-11 | D-0536-2026 |
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other recent recalls from Amerisource Health Services LLC
Editorial summary by Recall Canary · summary updated 2026-09-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification